X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1765) 1765
humans (1441) 1441
syndecan-1 (1132) 1132
animals (697) 697
female (694) 694
male (621) 621
syndecan-1 - metabolism (567) 567
syndecans (492) 492
middle aged (478) 478
mice (465) 465
expression (417) 417
aged (377) 377
adult (368) 368
oncology (366) 366
immunohistochemistry (340) 340
heparan-sulfate proteoglycans (317) 317
hematology (258) 258
biochemistry & molecular biology (254) 254
cancer (251) 251
cell biology (250) 250
syndecan-1 - genetics (231) 231
proteoglycans - metabolism (224) 224
cell line, tumor (221) 221
multiple myeloma (212) 212
pathology (210) 210
prognosis (203) 203
multiple myeloma - pathology (201) 201
membrane glycoproteins - metabolism (195) 195
syndecan (195) 195
proteoglycans (184) 184
gene expression (182) 182
analysis (179) 179
aged, 80 and over (177) 177
abridged index medicus (174) 174
heparan sulfate (172) 172
immunology (169) 169
proteoglycans - genetics (168) 168
cells, cultured (157) 157
membrane glycoproteins - genetics (157) 157
syndecan-1 - analysis (149) 149
cells (147) 147
flow cytometry (147) 147
multiple-myeloma (146) 146
research (143) 143
proteins (138) 138
article (133) 133
inflammation (133) 133
gene expression regulation, neoplastic (130) 130
activation (129) 129
cell line (125) 125
multiple myeloma - metabolism (123) 123
binding (121) 121
carbohydrates (119) 119
differentiation (118) 118
surgery (117) 117
plasma cells - pathology (116) 116
syndecan-1 expression (115) 115
tumors (115) 115
signal transduction (114) 114
receptor (111) 111
carcinoma (110) 110
cd138 (110) 110
adhesion (109) 109
growth (109) 109
metastasis (109) 109
proteoglycans - biosynthesis (109) 109
syndecan-1 - blood (109) 109
angiogenesis (108) 108
plasma cells - immunology (107) 107
membrane glycoproteins - analysis (106) 106
proteoglycans - analysis (106) 106
proteoglycan (105) 105
apoptosis (104) 104
cell proliferation (103) 103
research article (102) 102
tumor cells, cultured (102) 102
sulfates (101) 101
rats (99) 99
membrane glycoproteins - biosynthesis (97) 97
cell differentiation (96) 96
medicine (96) 96
mice, inbred c57bl (96) 96
in-vivo (95) 95
plasma cells - metabolism (93) 93
heparitin sulfate - metabolism (92) 92
syndecan-1 - biosynthesis (92) 92
plasma cells (90) 90
biopsy (88) 88
molecular sequence data (88) 88
survival (86) 86
syndecan-1 - immunology (85) 85
disease (84) 84
glycocalyx (84) 84
transfection (84) 84
glycosaminoglycans (83) 83
health aspects (83) 83
biomarkers, tumor - metabolism (82) 82
extracellular matrix (82) 82
phenotype (82) 82
reverse transcriptase polymerase chain reaction (82) 82
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1972) 1972
Chinese (24) 24
Japanese (11) 11
French (8) 8
Hungarian (6) 6
Korean (6) 6
German (5) 5
Czech (4) 4
Polish (3) 3
Portuguese (3) 3
Russian (2) 2
Spanish (2) 2
Italian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Wang, X and Zuo, D and Chen, Y and Li, W and Liu, R and He, Y and Ren, L and Zhou, L and Deng, T and Wang, X and Ying, G and Ba, Y
British Journal of Cancer, ISSN 0007-0920, 11/2014, Volume 111, Issue 10, pp. 1965 - 1976
Background: Syndecan-1 (Sdc-1) shedding induced by matrix metalloproteinase-7 (MMP-7) and additional proteases has an important role in cancer development.... 
colorectal cancer | syndecan-1 | HB-EGF | chemotherapy | ACTIVATION | SOLUBLE SYNDECAN-1 | METALLOPROTEINASE | TUMORS | LUNG-CANCER | VITRO CHEMOSENSITIVITY TEST | ONCOLOGY | ROLES | CELL-MIGRATION | GROWTH-FACTOR | EXPRESSION | RNA, Small Interfering - genetics | Apoptosis - drug effects | Humans | Syndecan-1 - genetics | Drug Resistance, Neoplasm | Male | Case-Control Studies | Immunoenzyme Techniques | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Flow Cytometry | Fluorouracil - administration & dosage | Neoplasm Grading | Matrix Metalloproteinase 7 - metabolism | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Camptothecin - administration & dosage | Female | Tumor Cells, Cultured | Paclitaxel - administration & dosage | Real-Time Polymerase Chain Reaction | Colorectal Neoplasms - metabolism | Camptothecin - analogs & derivatives | Syndecan-1 - metabolism | Neoplasm Invasiveness | RNA, Messenger - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Fluorescent Antibody Technique | Syndecan-1 - antagonists & inhibitors | Aged | Cell Proliferation - drug effects | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus | Translational Therapeutics
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2012, Volume 18, Issue 17, pp. 4850 - 4860
Journal Article
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 495 - 504
Increasing evidence suggests that tumour‐initiating cells ( TICs ) contribute to the development of prostate cancer. Here, we identified syndecan‐1 as a key... 
holoclone | syndecan‐1 | ROS | tumour‐initiating cells | tumour-initiating cells | syndecan-1 | SURVIVAL | NADPH OXIDASE | ANGIOGENESIS | HUMAN ALKB HOMOLOG | RADICAL PROSTATECTOMY | PATHOLOGY | HUMAN UROTHELIAL CARCINOMA | ONCOLOGY | HEPARAN-SULFATE PROTEOGLYCANS | BLADDER | EXPRESSION | MYELOMA | Neoplasm Transplantation | Prostatic Neoplasms - metabolism | Recurrence | Reactive Oxygen Species - metabolism | Taxoids - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Neoplasm Proteins - physiology | Syndecan-1 - genetics | NADPH Oxidases - metabolism | Male | Antineoplastic Agents - therapeutic use | Gene Knockdown Techniques | Prostatic Neoplasms - therapy | Taxoids - therapeutic use | Heterografts | Neoplastic Stem Cells - metabolism | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Neoplasm Proteins - genetics | Prostatic Neoplasms - pathology | Neoplasm Proteins - biosynthesis | Gene Silencing | Mice, Transgenic | Combined Modality Therapy | Mice, SCID | Cell Transformation, Neoplastic - metabolism | Disease Progression | Syndecan-1 - physiology | Animals | Syndecan-1 - biosynthesis | Prostatectomy | Aged | Mice | Cell Transformation, Neoplastic - pathology | Genetic Therapy - methods | Development and progression | Prostate cancer | Tumors | Index Medicus
Journal Article
Journal Article
Journal of Cell Science, ISSN 0021-9533, 08/2007, Volume 120, Issue 16, pp. 2851 - 2863
Journal Article
Carcinogenesis, ISSN 0143-3334, 01/2015, Volume 36, Issue 1, pp. 32 - 40
Syndecan-1 is highly overexpressed in dedifferentiated liposarcomas and high levels of syndecan-1 block adipocyte differentiation of human multipotent... 
HEPARANASE | HUMAN ADIPOSE-TISSUE | STEM-CELLS | METASTASIS | MECHANISM | ONCOLOGY | CD138 SYNDECAN-1 | GROWTH | ADIPOCYTIC DIFFERENTIATION | EXPRESSION | CANCER | Index Medicus
Journal Article
Molecular Oncology, ISSN 1574-7891, 03/2014, Volume 8, Issue 2, pp. 297 - 310
Journal Article